Search results
Results From The WOW.Com Content Network
Stimulant use disorder is a type of substance use disorder where the use of stimulants caused clinically significant impairment or distress. It is defined in the DSM-5 as "the continued use of amphetamine -type substances, cocaine , or other stimulants leading to clinically significant impairment or distress, from mild to severe". [ 1 ]
Stimulant psychosis is a mental disorder characterized by psychotic symptoms such as hallucinations, paranoid ideation, delusions, disorganized thinking, and grossly disorganized behaviour. It typically occurs following an overdose or several day binge on psychostimulants , [ 1 ] although it can occur in the course of stimulant therapy ...
A stimulant is an overarching term that covers many drugs including those that increase the activity of the central nervous system and the body, [5] drugs that are pleasurable and invigorating, or drugs that have sympathomimetic effects. [6]
Amphetamine [note 2] (contracted from alpha-methylphenethylamine) is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity; it is also used to treat binge eating disorder in the form of its inactive prodrug lisdexamfetamine.
For people who cannot be treated with stimulants due to a substance use disorder or other contraindications, atomoxetine is the suggested first-line treatment in the UK. In Canada, clinical guidelines suggest that first-line treatment be methylphenidate or lisdexamfetamine. [47] Non-stimulant medications are generally second-line treatments in ...
People treated with stimulants such as methylphenidate during childhood were less likely to have substance use disorders in adulthood. [ 210 ] Among countries with the highest rates of use of methylphenidate medication is Iceland, [ 211 ] where research shows that the drug was the most commonly used substance among people who inject drugs . [ 212 ]
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...